Indications and Purposes
| 1 Indications And Usage Idhifa Is An Isocitrate Dehydrogenase-2 Inhibitor Indicated For The Treatment Of Adult Patients With Relapsed Or Refractory Acute Myeloid Leukemia (Aml) With An Isocitrate Dehydrogenase-2 (Idh2) Mutation As Detected By An Fda-Approved Test ( 1.1 ). 1.1 Acute Myeloid Leukemia Idhifa Is Indicated For The Treatment Of Adult Patients With Relapsed Or Refractory Acute Myeloid Leukemia (Aml) With An Isocitrate Dehydrogenase-2 (Idh2) Mutation As Detected By An Fda-Approved Test. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Enasidenib Mesylate |